Skip to main content

Find Clinical Trials

Home
Conditions
Neoplastic Processes

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,270 public trials 686 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children

NCT01858740

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +41 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

NCT03665285

Conditions: Adenocarcinoma, Advanced or Metastatic Solid Tumors, Breast Cancer, +45 more
Locations: The Angeles Clinic and Research Institute Los Angeles, California, United States

Yale University Cancer Center New Haven, Connecticut, United States

John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

Laura and Isaac Perlmutter Cancer Center New York, United States

View Trial Details

Completed

Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

NCT01466036

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

SABR-SCAN Trial for Pulmonary Oligometastases

NCT02414334

Conditions: Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations: University Medical Center Groningen Groningen, Netherlands

View Trial Details

Completed

Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer

NCT01962324

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations: Umeå University, Cancercenter Umeå, Sweden

View Trial Details

Completed

Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis

NCT04594161

Conditions: Acute Kidney Injury, Bites and Stings, Calculi, +56 more
Locations: Amsterdam UMC, location AMC Amsterdam, North Holland, Netherlands

View Trial Details

Completed

EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity

NCT05809557

Conditions: Chemotherapeutic Toxicity, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1

NCT02034981

Conditions: Hematologic Cancers, Metastatic Cancer, Neoplasm Metastasis, +5 more
Locations: Gustave Roussy Villejuif, Île-de-France Region, France

View Trial Details

Completed

MEtronomic TrEatment Option in Advanced bReast cAncer

NCT02954055

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Centro di Riferimento Oncologico (CRO) Aviano, Italy

A.O.U. di Bologna Policlinico S. Orsola-Malpighi Viale Ercolani 4/2 Bologna, Italy

Ospedale di Bolzano Oncologia Medica Via lorenz Bohler 5 Bolzano, Italy

Aziendale Spedali Civili di Brescia SSVD Breast Unit P.le Spedali Civili 1 Brescia, Italy

View all 20 locations

View Trial Details

Completed

Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer

NCT02536742

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +8 more
Locations: Sint-Augustinus Antwerp, Belgium

Institut Jules Bodet Brussels, Belgium

Cliniques Universitaires Saint-Luc Brussels, Belgium

Antwerp University Hospital Edegem, Belgium

View all 19 locations

View Trial Details